Deloitte boosts Life Sciences & Health Care practice
pharmafile | February 12, 2010 | Appointment | Sales and Marketing |Â Â Deloitte, appointment, sales and marketingÂ
Business advisory firm Deloitte has made three senior appointments to its UK Life Sciences & Health Care practice.
Julian Remnant joins as an associate partner, M&A partner Malcolm Drysdale returns to the practice from a secondment in the Far East and IT expert Peter Wallace joins as a director.
Julian Remnant has 20 years of consulting experience gained at Accenture and has worked extensively within global pharmaceutical R&D.
He has led performance improvement programmes within drug development at pharmaceutical majors, biotechnology companies, contract research organisations and site management organisations.
Peter Wallace joins Deloitte from Accenture and is an expert in IT effectiveness and IT transformation.
He has 14 years industry experience across a number of sectors, specialising on the pharmaceutical sector for the last four years and working with a number of market-leading firms.
Malcolm Drysdale returns to the UK from a secondment with Deloitte’s Hong Kong firm, and will lead the company’s initiative to bring merger and acquisition insights to the pharmaceutical and biotech industries.
Related Content

David Wheadon appointed to board of directors at Seaport Therapeutics
This week, Seaport Therapeutics have appointed David Wheadon MD to their board of directors.

Myeloma UK reveals new Director of Research appointment
UK non-profit organisation Myeloma UK has selected Sarah McDonald as its new Director of Research, …

Abbott CEO to step down after 21 years
After more than two decades at the head of the company, it has emerged that …






